CADENCE: At-home Walking Cadence Functional Assessment and Recovery Trajectory for Older Adults Undergoing Major Surgery

Sponsor
University of Chicago (Other)
Overall Status
Recruiting
CT.gov ID
NCT05886725
Collaborator
(none)
100
1
24
4.2

Study Details

Study Description

Brief Summary

This is a prospective observational study looking at gait-cadence in older adults who are scheduled to have major abdominal surgery at the University of Chicago. The objective of the study is to evaluate whether gait-cadence, as measured from a patient's mobile device at-home, can provide an accurate assessment of a patient's functional status prior to major abdominal surgery and identify patients at risk of poor functional outcomes.

Condition or Disease Intervention/Treatment Phase
  • Other: Patients using Step Test Application and Accelerometer

Detailed Description

Over 100,000 older adults undergo elective major abdominal surgeries in the US each year and many experience loss of mobility after surgery that requires post-acute care. Risk of mobility loss is greater for older adults unable to engage in moderate-intensity physical activity before surgery. Additionally, recovery trajectories to baseline mobility remains poorly understood for older adults and may impact readmission. Functional status assessment before surgery can identify interventions to help older adults improve walking capacity and improve recovery trajectories after surgery. However, almost no patients receive objective functional status tests before surgery due to logistical and practical barriers. Remote assessments performed independently by the patient using wearable technology, such as smartphones, may provide a solution. Smartphone accelerometers combined with open-source software can directly measure a patient's gait-cadence, or the number of steps taken per minute. This observational cohort of older adults undergoing major abdominal surgery will use a novel smartphone application to obtain remotely collected gait-cadence from usual and fast paced walks prior to their in-clinic visit. Investigators will then compare the at-home to the in-clinic usual and fast paced walks and measure their recovery trajectory after surgery through weekly at-home walks. Overall mobility will be assessed using ActiGraph accelerometers worn for a 7-day time period before and after surgery. The investigator's hypothesis is that gait-cadence measured during usual and fast pace walks at-home will 1) provide an accurate and easy to use functional assessment 2) identify patients at-risk of mobility loss and 3) determine walking recovery trajectories for older adults after surgery. Results from this study will provide important knowledge on mobility trajectories of older adults after major abdominal surgery and develop a novel approach to identify high-risk older adults. Further, this platform may be leveraged to deliver mobility interventions before surgery to improve patient outcomes after surgery.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
At-home Walking Cadence Functional Assessment and Recovery Trajectory for Older Adults Undergoing Major Surgery
Actual Study Start Date :
Jan 2, 2023
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Jan 1, 2025

Outcome Measures

Primary Outcome Measures

  1. Accuracy of gait-cadence measured from at-home and in-clinic walk tests as measured by ActivPAL accelerometers. [Baseline (Before surgery)]

    ActivPAL accelerometer will be worn during in-clinic walk tests to serve as reference of steps walked during the at-home walk tests.

Secondary Outcome Measures

  1. Change in disability, as measured by the World Health Organization Disability Assessment Schedule (WHODAS) 2.0: 12-item. [Baseline (Before surgery), 1 month after surgery, 3 months after surgery]

    The simple sum of the scores of the 12-items range from 0 to 48 with higher scores indicating greater disability.

  2. Change in functional status, as measured by an interview in which participants will be asked, "At the present time, do you need help from another person to (complete the task)?" [Baseline (Before surgery), 1 month after surgery, 3 months after surgery]

    Interview question will be asked for 13 different tasks. An increased need for personal assistance demonstrates greater functional status decline.

  3. Change in global health, as measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Scale v1.2 - Global Health. [Baseline (Before surgery), 1 month after surgery, 3 months after surgery]

    Total raw scores are between 4 and 20, and these can be converted to a T-score. Higher scores mean more of the concept being measured. For example, higher scores mean more health.

  4. Change in pain interference, as measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form v1.1 - Pain Interference 6a. [Baseline (Before surgery), 1 month after surgery, 3 months after surgery]

    Total raw score ranges from 6 to 30, and these can be converted to a T-score. Higher scores indicate greater pain interference on relevant aspects of a participant's life.

  5. Change in gait-cadence after surgery [Weeks 1-8 after surgical procedure]

    Gait-cadence will be measured at-home after surgery from weekly at-home walking tests from smartphone

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patients > or = 65 years of age and scheduled for major abdominal surgery.

  • Access to a safe walking space roughly 30 ft in length. Safe walking spaces include a long hallway in the home, common use hallway in an apartment building or outside public area.

  • Able to walk independently with or without an assistive device (e.g. cane or walker)

Exclusion Criteria:
  • Inability to walk independently

  • Surgery scheduled less than 7-days after APMC appointment

  • Non-English speaking.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Chicago Medical Center Chicago Illinois United States 60637

Sponsors and Collaborators

  • University of Chicago

Investigators

  • Principal Investigator: Daniel Rubin, University of Chicago

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Chicago
ClinicalTrials.gov Identifier:
NCT05886725
Other Study ID Numbers:
  • IRB22-0556
First Posted:
Jun 2, 2023
Last Update Posted:
Jun 2, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by University of Chicago
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 2, 2023